0001061983-20-000189.txt : 20201217 0001061983-20-000189.hdr.sgml : 20201217 20201217180519 ACCESSION NUMBER: 0001061983-20-000189 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201215 FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cragg David CENTRAL INDEX KEY: 0001316459 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50633 FILM NUMBER: 201397319 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943291317 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 280 EAST GRAND AVENUE STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-12-15 0 0001061983 CYTOKINETICS INC CYTK 0001316459 Cragg David 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 SVP Human Resources Common Stock 2020-12-15 4 M 0 7423 9.42 A 147639 D Common Stock 2020-12-15 4 F 0 4745 21.0 D 142894 D Common Stock 2020-12-15 4 M 0 9243 9.42 A 152137 D Common Stock 2020-12-15 4 F 0 5908 21.0 D 146229 D Incentive Stock Option (right to buy) 9.42 2020-12-15 4 C 0 7423 0.0 D 2011-03-31 2021-02-28 Common Stock 7423 1 D Non-Qualified Stock Option (right to buy) 9.42 2020-12-15 4 C 0 7423 0.0 A 2011-03-31 2021-02-28 Common Stock 7423 16666 D Non-Qualified Stock Option (right to buy) 9.42 2020-12-15 4 M 0 7423 0.0 D 2011-03-31 2021-02-28 Common Stock 7423 9243 D Non-Qualified Stock Option (right to buy) 9.42 2020-12-15 4 M 0 9243 0.0 D 2011-03-31 2021-02-28 Common Stock 9243 0 D Includes up to 13,132 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan. Transaction represents a "net exercise" of 9,243 outstanding non-qualified stock options granted on 2/28/2011 and 7,423 outstanding non-qualified stock options that result from the conversion on 12/15/20 of incentive stock options granted on 2/28/2011. The Reporting Person received 6,013 shares of Common Stock on the net exercise of a stock options to purchase an aggregate of 16,666 shares of Common Stock, with a remaining payable by Reporting Person to the Issuer of $17.45. The Issuer withheld 10,653 shares of Common Stock underlying the stock options for payment of the exercise price and tax withholding using a stock price on 12/15/20 of $21.00. In addition to the withholding of 10,653 shares of Common Stock, the Reporting Person will pay $17.45 in cash to the Issuer for the remainder of his exercise price and tax liability. Incentive stock options granted on 2/28/2011 to purchase 7,423 shares at an exercise price of $9.42 per share converted to non-qualified stock options to purchase 7,423 shares at an exercise price of $9.42 per share as a result of a modification to the original grant to permit a "net exercise" of the stock options. Conversion transaction is permitted pursuant to the Issuer's Amended and Restated 2004 Equity Incentive Plan and the prior resolution of the Issuer's Compensation and Talent Committee of the Board of Directors. Number of derivative securities beneficially owned following reported transaction is zero (0). The 1 security that is reported is the result of rounding of shares attributable to Issuer?s reverse stock split that occurred on 6/25/2013. By: Robert Wong For: David Cragg 2020-12-17